Skip to main content
S. 1702 119th Congress Senate

Access to Prescription Digital Therapeutics Act of 2025

Official title: A bill to amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes.

Introduced: May 8, 2025 Introduced by: Shelley Moore Capito Republican · West Virginia See on congress.gov
Health
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 8, 2025
Read twice and referred to the Committee on Finance.
May 8, 2025
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now May 8, 2025

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Access to Prescription Digital Therapeutics Act of 2025

This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.

 Related & companion bills 1
  • HR 3288 Access to Prescription Digital Therapeutics Act of 2025
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 10

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • TIBER CREEK GROUP
    for ACADEMY OF MANAGED CARE PHARMACY · Virginia · 3rd Quarter 2026 (July 1 - Sep 30)
  • TIBER CREEK GROUP
    for ACADEMY OF MANAGED CARE PHARMACY · Virginia · 2nd Quarter 2026 (Apr 1 - June 30)
  • TIBER CREEK GROUP
    for ACADEMY OF MANAGED CARE PHARMACY · Virginia · 1st Quarter 2026 (Jan 1 - Mar 31)
  • BLUEBIRD STRATEGIES
    for ATA ACTION · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
  • TIBER CREEK GROUP
    for ACADEMY OF MANAGED CARE PHARMACY · Virginia · 4th Quarter 2025 (Oct 1 - Dec 31)
  • BLUEBIRD STRATEGIES
    for ATA ACTION · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 10 filings →
 Cosponsors 4
All 4 Democratic 2 Republican 2
R
Blackburn, Marsha
Tennessee · Jun 16, 2026
 R
Budd, Ted
North Carolina · Dec 10, 2025
 D
Booker, Cory A.
New Jersey · Jul 15, 2025
 D
Shaheen, Jeanne
New Hampshire · May 8, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1702: Access to Prescription Digital Therapeutics Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-1702/
MLA
"S. 1702: Access to Prescription Digital Therapeutics Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-1702/.
Bluebook (legal)
S. 1702, 119th Cong. (2026), https://openamerica.io/bill/119-S-1702/.
Markdown link
[S. 1702: Access to Prescription Digital Therapeutics Act of 2025](https://openamerica.io/bill/119-S-1702/)
Report a problem